HIV-1 infection, microenvironment and endothelial cell dysfunction.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  The New Microbiologica

• Publication date

  2016-07-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  PMID 27704142
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SIV/SHIV Infection Triggers Vascular Inflammation, Diminished Expression of Krüppel-like Factor 2 and Endothelial Dysfunction.

  2016cited by this paper
• Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17.

  2015influential reference
• How does the humoral response to HIV-2 infection differ from HIV-1 and can this explain the distinct natural history of infection with these two human retroviruses?

  2015cited by this paper
• HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking

  2015cited by this paper
• Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study.

  2014cited by this paper
• HIV envelope protein gp120-induced apoptosis in lung microvascular endothelial cells by concerted upregulation of EMAP II and its receptor, CXCR3.

  2014cited by this paper
• Simian Immunodeficiency Virus and Human Immunodeficiency Virus Type 1 Matrix Proteins Specify Different Capabilities To Modulate B Cell Growth

  2014influential reference
• HIV-1 Matrix Protein p17 Promotes Lymphangiogenesis and Activates the Endothelin-1/Endothelin B Receptor Axis

  2014influential reference
• Transfer of Intracellular HIV Nef to Endothelium Causes Endothelial Dysfunction

  2014influential reference
• Diverse Recombinant HIV-1 Envs Fail To Activate B Cells Expressing the Germline B Cell Receptors of the Broadly Neutralizing Anti-HIV-1 Antibodies PG9 and 447-52D

  2013cited by this paper
• HIV-related mechanisms in atherosclerosis and cardiovascular diseases

  2013cited by this paper
• Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals

  2013cited by this paper
• HIV infection and the risk of acute myocardial infarction.

  2013cited by this paper
• Lymphoid Tissue Damage in HIV-1 Infection Depletes Naïve T Cells and Limits T Cell Reconstitution after Antiretroviral Therapy

  2012cited by this paper
• Antiretroviral molecules and cardiovascular diseases.

  2012cited by this paper
• The role of cytokines in the establishment, persistence and eradication of the HIV reservoir.

  2012cited by this paper
• HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation.

  2012influential reference
• Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat protein.

  2012cited by this paper
• Analysis of the effects of HIV‐1 Tat on the survival and differentiation of vessel wall‐derived mesenchymal stem cells

  2012cited by this paper
• Directly Infected Resting CD4+T Cells Can Produce HIV Gag without Spreading Infection in a Model of HIV Latency

  2012cited by this paper
• HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2

  2012influential reference
• Opposite Effects of HIV-1 p17 Variants on PTEN Activation and Cell Growth in B Cells

  2011cited by this paper
• The immune system in atherosclerosis

  2011cited by this paper
• Imbalance between endothelial progenitors cells and microparticles in HIV-infected patients naive for antiretroviral therapy

  2011cited by this paper
• TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure.

  2010cited by this paper
• An update on the role of markers of inflammation in atherosclerosis.

  2010cited by this paper
• Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men

  2010cited by this paper
• Macrophage death and defective inflammation resolution in atherosclerosis

  2010cited by this paper
• Macrophage polarization and HIV‐1 infection

  2010cited by this paper
• Prevention of HIV Protease Inhibitor-Induced Dysregulation of Hepatic Lipid Metabolism by Raltegravir via Endoplasmic Reticulum Stress Signaling Pathways

  2010cited by this paper
• Endothelial progenitor cell trafficking in human immunodeficiency virus-infected persons

  2010cited by this paper
• HIV gp120 induces endothelial dysfunction in tumour necrosis factor-alpha-activated porcine and human endothelial cells.

  2010cited by this paper
• Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation.

  2010cited by this paper
• HIV Nef is Secreted in Exosomes and Triggers Apoptosis in Bystander CD4+ T Cells

  2010cited by this paper
• Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm

  2009cited by this paper
• Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study

  2009cited by this paper
• Prevention of atherosclerosis in patients living with HIV

  2009cited by this paper
• The immune response during acute HIV-1 infection: clues for vaccine development

  2009cited by this paper
• HIV Nef protein causes endothelial dysfunction in porcine pulmonary arteries and human pulmonary artery endothelial cells.

  2009cited by this paper
• Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection

  2009cited by this paper
• Endothelin-1 stimulates lymphatic endothelial cells and lymphatic vessels to grow and invade.

  2009cited by this paper
• The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease

  2009cited by this paper
• Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport.

  2009cited by this paper
• Potential Role of Interleukin-18 in the Immunopathogenesis of AIDS: Involvement in Fratricidal Killing of NK Cells

  2009cited by this paper
• Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections

  2009cited by this paper
• Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis

  2009cited by this paper
• Association of C-Reactive Protein and HIV Infection With Acute Myocardial Infarction

  2009cited by this paper
• Effects of HIV‐1 infection in vitro on transendothelial migration by monocytes and monocyte‐derived macrophages

  2009influential reference
• HIV infection and high density lipoprotein metabolism.

  2008cited by this paper
• Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection

  2008cited by this paper
• Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission

  2008cited by this paper
• HIV-1 Matrix Protein p17 Prevents Loss of CD28 Expression During IL-2–Induced Maturation of Naïve CD8+ T Cells

  2008influential reference
• Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy.

  2008cited by this paper
• The role of infectious agents in the pathogenesis of vasculitis

  2008cited by this paper
• Nef enhances HIV-1 infectivity via association with the virus assembly complex.

  2008cited by this paper
• HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype

  2008influential reference
• Induction of Plasma (TRAIL), TNFR-2, Fas Ligand, and Plasma Microparticles after Human Immunodeficiency Virus Type 1 (HIV-1) Transmission: Implications for HIV-1 Vaccine Design

  2008cited by this paper
• Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease.

  2007cited by this paper
• Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study).

  2007cited by this paper
• HIV‐1 matrix protein p17 binds to monocytes and selectively stimulates MCP‐1 secretion: role of transcriptional factor AP‐1

  2007influential reference
• Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1.

  2007cited by this paper
• HIV-1 protease inhibitors do not interfere with provirus transcription and host cell apoptosis induced by combined treatment TNF-alpha + TSA.

  2007cited by this paper
• Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study.

  2007cited by this paper
• HIV-1 induces cardiomyopathy by cardiomyocyte invasion and gp120, tat, and cytokine apoptotic signaling

  2007cited by this paper
• HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques.

  2006cited by this paper
• Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease.

  2006cited by this paper
• Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells

  2006cited by this paper
• Functions of the HIV-1 matrix protein p17.

  2006cited by this paper
• Circulating endothelial cells

  2005cited by this paper
• Human Immunodeficiency Virus Type 1 Nef Potently Induces Apoptosis in Primary Human Brain Microvascular Endothelial Cells via the Activation of Caspases

  2005cited by this paper
• The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis.

  2005cited by this paper
• Perils at mucosal front lines for HIV and SIV and their hosts

  2005cited by this paper
• Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy.

  2005cited by this paper
• Antiretroviral drug studies in nonhuman primates: a valid animal model for innovative drug efficacy and pathogenesis experiments.

  2005cited by this paper
• TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells.

  2005cited by this paper
• Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.

  2004cited by this paper
• Human endogenous retroviruses in health and disease: a symbiotic perspective.

  2004cited by this paper
• The causes and consequences of HIV evolution

  2004cited by this paper
• The chemokine system in diverse forms of macrophage activation and polarization.

  2004cited by this paper
• Apoptosis of uninfected cells induced by HIV envelope glycoproteins

  2004cited by this paper
• Human Immunodeficiency Virus Type 1 Nef-Mediated Downregulation of CD4 Correlates with Nef Enhancement of Viral Pathogenesis

  2003cited by this paper
• Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients

  2003cited by this paper
• The evolutionary adaptation of HIV-1 to specific immunity.

  2003cited by this paper
• HIV‐1 matrix protein p17 enhances the proliferative activity of natural killer cells and increases their ability to secrete proinflammatory cytokines

  2003influential reference
• The evolutionary adaptation of HIV-1 to specific immunity.

  2003cited by this paper
• Regulation of EMAP II by hypoxia.

  2003cited by this paper
• Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways

  2002cited by this paper
• Retroelement distributions in the human genome: variations associated with age and proximity to genes.

  2002cited by this paper
• HIV‐1 gp120 Proteins and gp160 Peptides Are Toxic to Brain Endothelial Cells and Neurons: Possible Pathway for HIV Entry into the Brain and HIV‐Associated Dementia

  2002cited by this paper
• HIV-1-induced production of endothelin-1 in an in vitro model of the human blood–brain barrier

  2002cited by this paper
• HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

  2002cited by this paper
• The HIV-1 Nef Protein and Phagocyte NADPH Oxidase Activation*

  2002cited by this paper
• HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor

  2002cited by this paper
• HIV preferentially infects HIV-specific CD4+ T cells

  2002cited by this paper
• Pathogenesis of HIV‐Related Pulmonary Hypertension

  2001cited by this paper
• Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years.

  2001cited by this paper
• HIV-1 receptors and cell tropism.

  2001cited by this paper
• Metabolic complications of HIV-1 antiretroviral therapy: the lipodystrophy syndrome.

  2001cited by this paper
• HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes.

  2001cited by this paper
• HIV-1 Tat Induces Microvascular Endothelial Apoptosis Through Caspase Activation1

  2001cited by this paper

• Prognostic significance of asymmetric dimethyl arginine level in pediatric patients with COVID-19 infection and MIS-C

  2025cites this paper
• HIV‐1 viral protein effect on cerebral microvasculature: An in vitro blood–brain barrier model

  2025cites this paper
• Molecular mechanisms of viral oncogenesis in haematological malignancies: perspectives from metabolic reprogramming, epigenetic regulation and immune microenvironment remodeling

  2025cites this paper
• HIV-Associated Hypertension: Risks, Mechanisms, and Knowledge Gaps

  2024cites this paper
• Delivering CRISPR to the HIV-1 reservoirs

  2024cites this paper
• Molecular mechanisms behind the generation of pro-oncogenic HIV-1 matrix protein p17 variants.

  2024cites this paper
• The effect of VEGF and KDR gene variants on Crimean-Congo hemorrhagic fever

  2024cites this paper
• Molecular Mechanisms Involved in the B Cell Growth and Clonogenic Activity of HIV-1 Matrix Protein p17 Variants

  2024cites this paper
• Detection of HIV-1 matrix protein p17 in sera of viremic or aviremic patients.

  2023cites this paper
• Occludin regulates HIV-1 infection by modulation of the interferon stimulated OAS gene family

  2023cites this paper
• Porcine Epidemic Diarrhea Virus Infection Disrupts the Nasal Endothelial Barrier To Favor Viral Dissemination

  2022cites this paper
• Incidence and risk factors of extrahepatic manifestations in patients with chronic HCV and HCV/HIV infection

  2022cites this paper
• Elevated Risk of Venous Thromboembolism in People Living with HIV

  2022cites this paper
• Viral Endothelial Dysfunction: A Unifying Mechanism for COVID-19

  2021cites this paper
• Synergistic Impairment of the Neurovascular Unit by HIV-1 Infection and Methamphetamine Use: Implications for HIV-1-Associated Neurocognitive Disorders

  2021cites this paper
• The HIV-1 Matrix Protein p17 Does Cross the Blood-Brain Barrier

  2021cites this paper
• Arterial stiffness is associated with oxidative stress and endothelial activation among persons with treated HIV in Zambia

  2021cites this paper
• Biomarkers of Endothelial Activation in Black South African HIV-Positive Subjects are Associated with Both High Viral Load and Low CD4 Counts

  2021cites this paper
• Circulating microparticles are increased amongst people presenting with HIV and advanced immune suppression in Malawi and correlate closely with arterial stiffness: a nested case control study [version 1; peer review: awaiting peer review]

  2021cites this paper
• Circulating microparticles are increased amongst people presenting with HIV and advanced immune suppression in Malawi and correlate closely with arterial stiffness: a nested case control study

  2021cites this paper
• HIV co-receptor-tropism: cellular and molecular events behind the enigmatic co-receptor switching

  2021cites this paper
• HIV Associated Preeclampsia: A Multifactorial Appraisal

  2021cites this paper
• Incidence of Hypertension among Persons Living with HIV in China A Multicenter Study

  2020cites this paper
• Role of Autophagy in Von Willebrand Factor Secretion by Endothelial Cells and in the In Vivo Thrombin-Antithrombin Complex Formation Promoted by the HIV-1 Matrix Protein p17

  2020cites this paper
• Hysterosalpingographic evaluation of human immunodeficiency virus-infected and uninfected infertile women

  2020cites this paper
• Incidence of hypertension among persons living with HIV in China: a multicenter cohort study

  2020cites this paper
• Myeloid C-Type Lectin Receptors in Tuberculosis and HIV Immunity: Insights Into Co-infection?

  2020cites this paper
• The Signature Amino Acid Residue Serine 31 of HIV-1C Tat Potentiates an Activated Phenotype in Endothelial Cells

  2020cites this paper
• Supplementing Glycine and N-acetylcysteine (GlyNAC) in Aging HIV Patients Improves Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Endothelial Dysfunction, Insulin Resistance, Genotoxicity, Strength, and Cognition: Results of an Open-Label Clinical Trial

  2020cites this paper
• Endothelial activation is associated with intestinal epithelial injury, systemic inflammation and treatment regimen in children living with vertically acquired HIV‐1 infection

  2020cites this paper
• HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus Replication

  2020cites this paper
• Circulating Microparticles are increased amongst people presenting with HIV and advanced immune suppression in Malawi and correlate closely with arterial stiffness

  2020cites this paper
• Reverse Transcriptase Inhibitors Nanosystems Designed for Drug Stability and Controlled Delivery

  2019cites this paper
• HIV-1 Reverse Transcriptase Promotes Tumor Growth and Metastasis Formation via ROS-Dependent Upregulation of Twist

  2019cites this paper
• Extracellular vesicles from T cells overexpress miR-146b-5p in HIV-1 infection and repress endothelial activation

  2019cites this paper
• Effects of HIV-1 gp120 and TAT-derived microvesicles on endothelial cell function.

  2019influential citation
• Optimizing HIV prevention and care for transgender adults

  2019cites this paper
• The role of integration and clonal expansion in HIV infection: live long and prosper

  2018cites this paper
• Vascular endothelial dysfunction in the wake of HIV and ART

  2018cites this paper
• Infectious Agents in Atherosclerotic Cardiovascular Diseases through Oxidative Stress

  2017cites this paper
• Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis

  2017cites this paper
• HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressiveness

  2017cites this paper
• HIV-1 infection in early human placenta in vitro: Effects of Tumor Necrosis Factor (TNF-α) and Interleukins IL-1 and IL-6

  2016cites this paper